BKV Corp

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows 424B2 and confirms the priced prospectus.

Price $26.58 · 9,692,089 shares · Gross proceeds $147,500,000

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 1,453,813 · Underwriters RBC Capital Markets

2026-03-12 · 0001104659-26-026522

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows 424B5 and confirms the priced prospectus.

Price $26.58 · 9,692,089 shares · Gross proceeds $147,500,000

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 1,453,813 · Underwriters RBC Capital Markets

2026-03-12 · 0001104659-26-026540

424B2 filed

Prospectus supplement

Prospectus supplement that can carry timing details without itself confirming imminent trading.

Follows 424B5 in the pre-IPO sequence.

9,692,089 shares

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 1,453,813 · Use of proceeds The company will not receive proceeds from the selling stockholder's shares. · Underwriters RBC Capital Markets

2026-03-10 · 0001104659-26-025876

424B2 filed

Prospectus supplement

Prospectus supplement that can carry timing details without itself confirming imminent trading.

Follows 424B2 in the pre-IPO sequence.

9,692,089 shares

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 1,453,813 · Underwriters RBC Capital Markets

2026-03-10 · 0001104659-26-025879

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

Price $26.00 · 6,000,000 shares · Gross proceeds $156,000,000

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 900,000 · Underwriters Citigroup, Barclays, Mizuho

2025-12-03 · 0001104659-25-117970

424B2 filed

Prospectus supplement

Prospectus supplement that can carry timing details without itself confirming imminent trading.

Follows 424B4 in the pre-IPO sequence.

6,000,000 shares

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 900,000 · Underwriters Citigroup, Barclays, Mizuho

2025-12-01 · 0001104659-25-117338

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B2 and marks the registration effective.

2025-12-01 · 9999999995-25-003434

424B4 priced

Final prospectus

Final prospectus filed after pricing with final deal terms.

Follows EFFECT and confirms the priced prospectus.

Price $18.00 · 15,000,000 shares · Gross proceeds $270,000,000

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 2,250,000 · Use of proceeds general corporate purposes · Underwriters Citigroup, Barclays, Evercore ISI

2024-09-27 · 0001104659-24-103216

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows S-1/A in the pre-IPO sequence.

2024-09-25 · 0000876661-24-000876

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows CERT and registers the class of securities for exchange listing.

2024-09-25 · 0001104659-24-102644

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 8-A12B and marks the registration effective.

2024-09-25 · 9999999995-24-002956

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $19.00 · Range $19.00 to $21.00 · 15,000,000 shares

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 2,250,000 · Use of proceeds for general corporate purposes · Underwriters Citigroup, Barclays, Evercore ISI

2024-09-20 · 0001104659-24-101550

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Range $19.00 to $21.00 · 15,000,000 shares

Common Stock · Exchange NYSE · Ticker BKV · Over-allotment 2,250,000 · Use of proceeds general corporate purposes · Underwriters Citigroup, Barclays, Evercore ISI

2024-09-16 · 0001104659-24-099966

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters Citigroup, Barclays, Evercore ISI

2024-09-09 · 0001104659-24-098078

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters Citigroup, Barclays, Evercore ISI

2024-08-28 · 0001104659-24-093991

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Use of proceeds for general corporate purposes · Underwriters Citigroup, Barclays, Evercore ISI

2024-08-13 · 0001104659-24-088540

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters Citigroup, Barclays, Evercore ISI

2024-07-05 · 0001104659-24-078042

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters BofA Securities, Barclays, Citigroup

2024-01-12 · 0001104659-24-003646

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Use of proceeds General corporate purposes · Underwriters BofA Securities, Barclays, Citigroup

2023-10-06 · 0001104659-23-107566

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters BofA Securities, Barclays, Citigroup

2023-09-12 · 0001104659-23-099968

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock

2023-06-27 · 0001104659-23-075202

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters BofA Securities, Barclays, Citigroup

2023-06-26 · 0001104659-23-074797

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Use of proceeds General corporate purposes · Underwriters Credit Suisse, BofA Securities, Barclays

2023-04-14 · 0001104659-23-045555

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Use of proceeds Proceeds will be used for general corporate purposes, including debt repayment, working capital, and potential acquisitions. · Underwriters Credit Suisse, BofA Securities, Barclays

BKV Corporation, an emerging growth company, is conducting its initial public offering (IPO) of common stock, with shares expected to be listed on the NYSE under the symbol 'BKV.' The offering includes a 30-day underwriter option to purchase additional shares. Post-IPO, affiliates of Banpu Public Company Limited will hold significant voting power, classifying BKV as a 'controlled company' under NYSE rules. The prospectus highlights risks related to market volatility, operational complexities, and regulatory compliance.

2023-01-18 · 0001104659-23-004330

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Common Stock · Exchange NYSE · Ticker BKV · Underwriters Credit Suisse, BofA Securities, Barclays

BKV Corporation, an emerging growth company, is conducting its initial public offering (IPO) of common stock, with shares expected to be listed on the NYSE under the symbol 'BKV.' The offering includes a 30-day option for underwriters to purchase additional shares. Post-offering, affiliates of Banpu Public Company Limited will hold a significant voting stake, classifying BKV as a 'controlled company' under NYSE rules. The filing highlights risks associated with market conditions, operational challenges, and regulatory compliance.

2022-12-22 · 0001104659-22-129511

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

Common Stock of BKV Corporation · Exchange NYSE · Ticker BKV · Underwriters Credit Suisse, BofA Securities, Barclays

BKV Corporation is conducting its initial public offering (IPO) of common stock, with an anticipated price range and listing on the NYSE under the symbol 'BKV.' The company, an emerging growth company, has granted underwriters a 30-day option to purchase additional shares. Post-IPO, affiliates of Banpu Public Company Limited will hold significant voting power, making BKV a 'controlled company' under NYSE rules. The prospectus highlights risks associated with the offering and market conditions.

2022-12-09 · 0001104659-22-125862

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

Common Stock of BKV Corporation · Exchange NYSE · Ticker BKV · Underwriters Credit Suisse, BofA Securities, Barclays

BKV Corporation is conducting its initial public offering (IPO) of common stock, with no prior public market for its shares. The offering price is anticipated to be between $X and $Y per share, with plans to list on the NYSE under the symbol 'BKV.' The company has granted underwriters a 30-day option to purchase additional shares. BKV is an emerging growth company, electing reduced reporting requirements. Post-offering, affiliates of Banpu Public Company Limited will hold significant voting power, making BKV a 'controlled company' under NYSE rules.

2022-11-18 · 0001104659-22-120237

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS/A filing.

BKV Corp is conducting its initial public offering (IPO) of common stock, with shares expected to be listed on the NYSE under the symbol 'BKV.' The offering includes an underwriter option to purchase additional shares. BKV is an emerging growth company, electing reduced reporting requirements, and will become a 'controlled company' post-offering due to significant ownership by Banpu Public Company Limited affiliates. The filing emphasizes risks outlined in the 'Risk Factors' section, with no public market for shares prior to the IPO.

2022-10-26 · 0001104659-22-111293

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

BKV Corporation is conducting an initial public offering (IPO) of its common stock, with an anticipated price range of $X.XX to $X.XX per share. The company plans to list on the NYSE under the symbol 'BKV' and has granted underwriters a 30-day option to purchase additional shares. BKV is an emerging growth company and will be classified as a 'controlled company' post-offering due to Banpu Public Company Limited's significant ownership. The filing includes pro forma financial data reflecting the Exxon Barnett Acquisition and related financing.

2022-09-16 · 0001104659-22-100512

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

BKV Corp, a Delaware corporation, is conducting an initial public offering (IPO) of its common stock, with an anticipated price range and planned listing on the NYSE under the symbol 'BKV.' The company is an emerging growth company and has granted underwriters a 30-day option to purchase additional shares. Affiliates of Banpu Public Company Limited will beneficially own approximately [X]% of voting power, making BKV a 'controlled company' under NYSE rules. The filing includes a risk factors section highlighting potential investment risks.

2022-08-12 · 0001104659-22-089860

Filing Timeline

Recent News